Top compounds associated with response to RWDD4


Feature Type Standardized
Nominal ANOVA
mRNA tigecycline CTRPv2 pan-cancer AAC 0.12 0.01
mRNA ML203 CTRPv2 pan-cancer AAC -0.094 0.01
mRNA KX2-391 CTRPv2 pan-cancer AAC 0.079 0.01
mRNA PD318088 CTRPv2 pan-cancer AAC -0.086 0.01
mRNA selumetinib:BRD-A02303741 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.084 0.02
mRNA parbendazole CTRPv2 pan-cancer AAC 0.074 0.02
mRNA ifosfamide CTRPv2 pan-cancer AAC 0.13 0.02
mRNA nakiterpiosin CTRPv2 pan-cancer AAC 0.079 0.02
mRNA selumetinib:UNC0638 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.084 0.02
mRNA Teniposide CTRPv2 pan-cancer AAC 0.093 0.02
Download CSV